India · Delayed Price · Currency is INR Verve Therapeutics Statistics
Total Valuation
BOM:500300 has a market cap or net worth of INR 1.83 trillion. The enterprise value is 4.07 trillion.
| Market Cap | 1.83T |
| Enterprise Value | 4.07T |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Aug 6, 2024 |
Share Statistics
| Current Share Class | 678.52M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.24% |
| Shares Change (QoQ) | +0.79% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 333.45M |
Valuation Ratios
The trailing PE ratio is 45.10 and the forward PE ratio is 162.22.
| PE Ratio | 45.10 |
| Forward PE | 162.22 |
| PS Ratio | 1.19 |
| PB Ratio | 1.16 |
| P/TBV Ratio | 2.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 100.42 |
| EV / Sales | 2.64 |
| EV / EBITDA | 13.31 |
| EV / EBIT | 16.99 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 6.21 |
| Debt / FCF | n/a |
| Interest Coverage | 1.79 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 4.73% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 56.35M |
| Profits Per Employee | 1.48M |
| Employee Count | 27,327 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:500300 has paid 35.11 billion in taxes.
| Income Tax | 35.11B |
| Effective Tax Rate | 29.33% |
Stock Price Statistics
The stock price has increased by +3.99% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +3.99% |
| 50-Day Moving Average | 2,733.93 |
| 200-Day Moving Average | 2,601.49 |
| Relative Strength Index (RSI) | 41.00 |
| Average Volume (20 Days) | 30,937 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:500300 had revenue of INR 1.54 trillion and earned 40.49 billion in profits. Earnings per share was 60.34.
| Revenue | 1.54T |
| Gross Profit | 888.95B |
| Operating Income | 236.05B |
| Pretax Income | 119.68B |
| Net Income | 40.49B |
| EBITDA | 297.41B |
| EBIT | 236.05B |
| Earnings Per Share (EPS) | 60.34 |
Balance Sheet
The company has 238.75 billion in cash and 1.88 trillion in debt, giving a net cash position of -1,636.81 billion.
| Cash & Cash Equivalents | 238.75B |
| Total Debt | 1.88T |
| Net Cash | -1,636.81B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.58T |
| Book Value Per Share | 1,437.10 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 57.73%, with operating and profit margins of 15.33% and 2.63%.
| Gross Margin | 57.73% |
| Operating Margin | 15.33% |
| Pretax Margin | 7.77% |
| Profit Margin | 2.63% |
| EBITDA Margin | 19.31% |
| EBIT Margin | 15.33% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 10.00, which amounts to a dividend yield of 0.36%.
| Dividend Per Share | 10.00 |
| Dividend Yield | 0.36% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.24% |
| Shareholder Yield | -0.87% |
| Earnings Yield | 2.22% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 6, 2016. It was a forward split with a ratio of 5.
| Last Split Date | Oct 6, 2016 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |